Jin Medical Announces the Official Commencement Date of Chuzhou Facility

Core Viewpoint - Jin Medical International Ltd. is advancing its manufacturing capabilities with the construction of a new facility in Chuzhou, Anhui Province, expected to enhance production of mid-to-high-end electric wheelchairs and senior mobility scooters, aligning with the growing global demand for assistive devices driven by aging populations [1][4]. Company Developments - The Chuzhou facility is projected to achieve full production capacity by the end of April 2026, with an annual output capacity of 200,000 units [1]. - The facility has received regulatory approval for Class I Medical Device production, completing necessary filings with local authorities on December 29, 2025 [1]. - The new facility will utilize automated production lines to improve cost control and product quality consistency [3]. Strategic Importance - The Chuzhou facility is strategically located in the Yangtze River Delta's manufacturing hub, providing geographical and supply chain advantages [2]. - The project is expected to significantly enhance Jin Medical's manufacturing capabilities in premium mobility products, thereby improving market competitiveness [4]. - The completion of this project supports the company's strategic goal of optimizing global production capacities and enhancing supply chain resilience [3]. Industry Context - The expansion of Jin Medical coincides with a growing global demand for assistive devices, driven by the aging trend [4]. - The facility's efficient scaled production is anticipated to create sustained value for shareholders through effective execution of the project [4]. Company Background - Jin Medical, founded in 2006, designs, develops, manufactures, and markets wheelchairs and living aids for people with disabilities and the elderly [5]. - The company currently operates two manufacturing plants totaling approximately 230,000 square feet and is establishing a new facility of 430,000 square feet in Chuzhou [5]. - Jin Medical collaborates with over 40 distributors in China and more than 20 international distributors, with a significant portion of its products sold in Japan and China [5].